Novel multi-kinase inhibitor, T03 inhibits Taxol-resistant breast cancer

Activation of kinase-associated signaling pathways is one of the leading causes of various malignant phenotypes in breast tumors. Strategies of drug discovery and development have investigated approaches to target the inhibition of protein kinase signaling. In the current study, the anti-tumor activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Liu, Chunxia, Tang, Ke, Chen, Yan, Tian, Kang, Feng, Zhiqiang, Chen, Jindong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783483/
https://www.ncbi.nlm.nih.gov/pubmed/29207185
http://dx.doi.org/10.3892/mmr.2017.8179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783483/
https://www.ncbi.nlm.nih.gov/pubmed/29207185
http://dx.doi.org/10.3892/mmr.2017.8179

Ejemplares similares